渗透(HVAC)
敌手
肝损伤
肽
化学
药理学
医学
癌症研究
细胞生物学
生物
材料科学
生物化学
受体
复合材料
作者
Eline Geervliet,Sahil Arora,Dagmara S. Donohue,Carlos Antônio de Albuquerque Pinheiro,Leon W.M.M. Terstappen,Richard B. M. Schasfoort,Julieta I. Paez,Raj Kumar,Ruchi Bansal
标识
DOI:10.1016/j.apsb.2025.02.018
摘要
During liver injury, intrahepatic macrophage compartment is augmented by circulating monocytes that infiltrate the liver driven by C–C motif chemokine ligand/C–C motif chemokine receptor (CCL/CCR) axis including CCL1‒CCR8 axis, thereby contributing to liver inflammation. Numerous small molecular receptor antagonists , including R243, have been developed for targeting CCR8; however, these agents face challenges in clinical translation, potentially attributed to their poor pharmacokinetic profiles, lack of target specificity, and potential adverse effects . In this study, we designed four CCR8 antagonizing peptides (AP8i-AP8iv) and performed molecular characterization in silico and therapeutic investigation in vitro and in vivo . Based on in silico docking, molecular dynamic simulation using homology build model and in-vitro (competitive) binding studies, AP8ii (YEWRFYHG) evidenced highly favorable and selective interactions at the CCR8-active site. AP8ii inhibited CCL1-driven chemotaxis and LPS/IFN γ -induced pro-inflammatory activation of monocytes-macrophages in vitro . In a CCl 4 -induced acute liver injury mouse model, AP8ii treatment decreased intrahepatic infiltration of circulating monocytes . Moreover, AP8ii reduced liver inflammation, as indicated by decreased F4/80, IL6 and iNOS expression, diminished ALT levels, and attenuated fibrosis , as indicated by reduced collagen-I expression. In conclusion, we report a novel CCR8-antagonizing peptide that inhibited CCL1-driven intrahepatic monocytes infiltration and differentiation into pro-inflammatory phenotype, consequently ameliorating liver inflammation and fibrogenesis in an acute liver injury mouse model.
科研通智能强力驱动
Strongly Powered by AbleSci AI